<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03386097</url>
  </required_header>
  <id_info>
    <org_study_id>DiabetesIC2</org_study_id>
    <nct_id>NCT03386097</nct_id>
  </id_info>
  <brief_title>Interstitial Fluid in the Development of Cardiovascular Disease</brief_title>
  <official_title>Studies of the Importance of Interstitial Fluid in the Development of Cardiovascular Disease, an Expanded Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At a given level of serum cholesterol, patients with T2D have an increased risk of developing
      atherosclerosis compared with nondiabetic subjects.

      In a previous study we showed that the interstitial fluid-to-serum gradient of LDL and VLDL
      cholesterol is reduced in T2D patients compared with healthy controls. This was not found for
      HDL cholesterol. However, the cholesterol transporting function of HDL particles from
      interstitial fluid from patients with T2D were lower than in healthy controls. We hypothesize
      that that the apo B-containing particles in T2D patients are more susceptible to be retained
      or consumed in the extravascular space.

      We are to study if skin biopsies from T2D patients contain more cholesterol than biopsies
      from healthy controls. We hypothesize that samples from T2D patients are richer in
      cholesterol, which could explain why VLDL and LDL cholesterol are lower in relation to their
      plasma levels in T2D.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 10, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Interstitial fluid-to-serum ratio for LDL cholesterol</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cholesterol level in skin biopsies</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type2 Diabetes</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetes patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of interstitial fluid, skin biopsies and blood</intervention_name>
    <description>Collection of interstitial fluid, skin biopsies and blood</description>
    <arm_group_label>Type 2 diabetes patients</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Interstitial fluid, skin biopsies and blood (serum, plasma and whole blood)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy controls and type 2 diabetes patients over 18 years old, matched for age and
        gender.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years.

          -  For the T2D study group: Diagnosed with type 2 diabetes.

        Exclusion Criteria:

          -  Pregnancy

          -  Markers for thyroid disease or inflammation out of normal range.

          -  Self-reporting thyriod disease, inflammatory disease, kidney disease or cutaneous
             diseases.

          -  Self-reporting asthma or COPD treated with oral glucocorticoids.

        Additional exclusion criteria for the healthy controls:

          -  Blood Pressure &gt;140/90.

          -  Blood lipids or glucose out of normal range.

          -  Markers for liver or kidney function out of normal range.

          -  Self-reporting type 2 diabetes or cardiovascular disease.

          -  Drug treatment (excl. contraception and antihistamines).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mats Rudling</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mats Rudling</last_name>
    <phone>+46 8585 869 55</phone>
    <email>mats.rudling@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Patient research centre, Clinic of endocrinology, Karolinska University Hospital</name>
      <address>
        <city>Huddinge</city>
        <state>Stockholm</state>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2017</study_first_submitted>
  <study_first_submitted_qc>December 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2017</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Mats Rudling</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>Cholesterol</keyword>
  <keyword>Interstitial fluid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

